104 related articles for article (PubMed ID: 3838784)
21. Penbutolol and molsidomine synergism in angina pectoris. A double blind ergometric trial.
Balestrini AE; Menzio AC; Cabral R; Feldman R; Mercogliano C; Flichtentrei D; Albera HP; Vazquez A
Eur J Clin Pharmacol; 1984; 27(1):1-5. PubMed ID: 6386486
[TBL] [Abstract][Full Text] [Related]
22. [Synergic action of molsidomine and atenolol in patients with exertion angina. Cycloergometric study].
Gimeno JV; Olagüe J; Bueno FJ; Tellols R; Martín G; Ferrer J
Med Clin (Barc); 1984 Nov; 83(15):624-8. PubMed ID: 6549203
[No Abstract] [Full Text] [Related]
23. [Ergometric study of a new vasodilator agent in angina: molsidomine. Value of combination with beta-blockaders].
Witchitz S; Kolsky H; Moisson P; Valette H
Arch Mal Coeur Vaiss; 1981 Apr; 74(4):463-71. PubMed ID: 6112971
[TBL] [Abstract][Full Text] [Related]
24. [Anti-ischemic effect of 8 mg molsidomin in retard form].
Blasini R; Brügmann U; Rudolph W
Herz; 1984 Dec; 9(6):346-52. PubMed ID: 6392050
[TBL] [Abstract][Full Text] [Related]
25. The antianginal effect of molsidomine in prolonged oral therapy. A double blind, crossover, randomized study.
Baudry C
Acta Cardiol; 1982; 37(1):23-30. PubMed ID: 7044013
[TBL] [Abstract][Full Text] [Related]
26. [Effectiveness of using corvaton on patients with unstable stenocardia].
Vakaliuk IP
Vrach Delo; 1984 Nov; (11):18-21. PubMed ID: 6442043
[No Abstract] [Full Text] [Related]
27. Evaluation of the chronic antianginal effect of molsidomine.
Dalla-Volta S; Scorzelli L; Razzolini R
Am Heart J; 1985 Mar; 109(3 Pt 2):682-4. PubMed ID: 3883736
[TBL] [Abstract][Full Text] [Related]
28. Hemodynamic effects of molsidomine at rest and during submaximal and maximal exercise in patients with coronary artery disease limited by exertional angina pectoris.
Detry JM; Melin J; Brasseur LA; Cosyns J; Rousseau MF
Am J Cardiol; 1981 Jan; 47(1):109-15. PubMed ID: 6893896
[TBL] [Abstract][Full Text] [Related]
29. [Treatment with sidnonimine derivatives of chronic ischemic heart disease patients].
Kuz'ko NV
Vrach Delo; 1984 Jul; (7):79-81. PubMed ID: 6548063
[No Abstract] [Full Text] [Related]
30. Effects of molsidomine on global and regional left ventricular function at rest and during exercise in patients with angina pectoris.
Nechwatal W; Stauch M; Sigel H; Kress P; Bitter F; Geffers H; Adam WE
Clin Cardiol; 1981; 4(5):248-53. PubMed ID: 6895491
[No Abstract] [Full Text] [Related]
31. Clinical and hemodynamic effects of the new dilator drug molsidomine.
Malcolm AD
Am Heart J; 1985 Mar; 109(3 Pt 2):674-7. PubMed ID: 3883734
[TBL] [Abstract][Full Text] [Related]
32. [Experience with molsidomin].
Schlimmer P
ZFA (Stuttgart); 1980 Mar; 56(9):610-1. PubMed ID: 7376699
[No Abstract] [Full Text] [Related]
33. [The classic anti-anginal agents and molsidomine].
Vacheron A
Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():71-5. PubMed ID: 6407452
[TBL] [Abstract][Full Text] [Related]
34. [Effect duration and dose-response relation of molsidomine in patients with coronary heart disease].
Fach WA; Becker HJ
Z Kardiol; 1984 Oct; 73(10):613-22. PubMed ID: 6393621
[TBL] [Abstract][Full Text] [Related]
35. Molsidomine--an effective antianginal drug. Results of an acute randomized stress-testing study.
Mindlin de Aptecar FR; Vazquez A; Aptecar M
Cardiology; 1985; 72(4):185-92. PubMed ID: 3902224
[TBL] [Abstract][Full Text] [Related]
36. [Effect of molsidomine on cardiac function in experimental transitory coronary insufficiency].
Litvitskiĭ PF; Ol'binskaia LI; Sandrikov VA; Aksiuk MA
Kardiologiia; 1981 Apr; 21(4):71-4. PubMed ID: 6894773
[TBL] [Abstract][Full Text] [Related]
37. [Clinical evaluation of molsidomin in ischemic cardiopathy].
Di Giacomo G; Nicolella U; Puligheddu M; Tripodi A; D'Ascoli C; Di Virgilio D
Clin Ter; 1984 Oct; 111(2):141-6. PubMed ID: 6239736
[No Abstract] [Full Text] [Related]
38. Hemodynamic effects of molsidomine.
Rakovec P
J Cardiovasc Pharmacol; 1980; 2(6):893-4. PubMed ID: 6160337
[No Abstract] [Full Text] [Related]
39. [Molsidomine in exertion angina].
Witchitz S; Kolsky H; Moisson P
Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):539-43. PubMed ID: 6689396
[TBL] [Abstract][Full Text] [Related]
40. [Effect of molsidomin and nifedipine on tolerance of physical exertion among rheumatic fever patients in the initial stage of heart failure].
Sokolov AM
Vrach Delo; 1986 Jan; (1):32-5. PubMed ID: 3754076
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
